ImmunityBio
IBRX
$4.16
Share price
5.58%
Change (1 day)
N/A
Change (1 year)
Categories
Earnings for ImmunityBio (IBRX)
Earnings in 2022 (TTM): -$0.36 B
According to ImmunityBio's latest financial reports the company's current earnings (TTM) are -$0.36 B. In 2021 the company made an earning of -$0.34 B a decrease over its 2020 earnings that were of -$0.22 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for ImmunityBio from 2020 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.36 B | 5.13% |
| 2021 | -$0.34 B | 54.4% |
| 2020 | -$0.22 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.09 B | -75.70% | 🇺🇸 USA |